Fredrik Hellem Schjesvold

  • Head of Oslo Myeloma Center PhD, MD
  • +47 996 97 796

Oslo Myeloma Center

Group leader: Fredrik Schjesvold, MD
Associated research doctors: Nina Gulbrandsen, MD PhD, Puneet Kaur, MD
Study nurses: Ulla MadsenMarrydith Tran, Kristin Låstad, Larisa Myrseth

Associated research groups

About our research



Søkeord: Myelomatose forskning


Author network for Fredrik Hellem Schjesvold by COREMINE medical

Publications 2017

Schjesvold FH (2017)
[No title available]
Tidsskr Nor Laegeforen, 137 (1), 58
PubMed 28073239

Wang D, Fløisand Y, Myklebust CV, Bürgler S, Parente-Ribes A, Hofgaard PO, Bogen B, Taskén K, Tjønnfjord GE, Schjesvold F, Dalgaard J, Tveita A, Munthe LA (2017)
Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice
Leukemia, 31 (10), 2114-2121
PubMed 28232741

Publications 2016

Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S (2016)
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
Clin Microbiol Infect, 23 (3), 179-187
PubMed 27793737

Publications 2015

Tveita AA, Schjesvold F, Haabeth OA, Fauskanger M, Bogen B (2015)
Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens
Cancer Res, 75 (16), 3268-78
PubMed 26038231

Publications 2014

Haabeth OA, Tveita AA, Fauskanger M, Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic Z, Corthay A, Bogen B (2014)
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
Front Immunol, 5, 174
PubMed 24782871

Tveita AA, Schjesvold FH, Sundnes O, Haabeth OA, Haraldsen G, Bogen B (2014)
Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells
Eur J Immunol, 44 (9), 2625-37
PubMed 24846412

Publications 2013

Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
[Investigation of anemia]
Tidsskr Nor Laegeforen, 133 (6), 610
PubMed 23552139

Schjesvold FH (2013)
[Investigation of amyloidosis]
Tidsskr Nor Laegeforen, 133 (3), 266
PubMed 23381155

Publications 2012

Tazmini K, Bakken HN, Schjesvold FH (2012)
A woman in her seventies with reduced general condition, dyspnoea and generalised pain
Tidsskr Nor Laegeforen, 132 (17), 1969-72
PubMed 23007363

Publications 2009

Schjesvold FH (2009)
[Erythrocytosis as a problem]
Tidsskr Nor Laegeforen, 129 (22), 2387; author reply 2387
PubMed 19935946

Publications 2008

Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L (2008)
[High-dose treatment of systemic AL-amyloidosis with autologous stem cell support]
Tidsskr Nor Laegeforen, 128 (12), 1392-6
PubMed 18552900

Mar 27, 2015 Page visits: 7068